244 related articles for article (PubMed ID: 36028591)
1. Physiologically based pharmacokinetic (PBPK) modeling of flurbiprofen in different CYP2C9 genotypes.
Whang SS; Cho CK; Jung EH; Kang P; Park HJ; Lee YJ; Choi CI; Bae JW; Kim HS; Jang CG; Lee SY
Arch Pharm Res; 2022 Aug; 45(8):584-595. PubMed ID: 36028591
[TBL] [Abstract][Full Text] [Related]
2. Physiologically based pharmacokinetic (PBPK) modeling of piroxicam with regard to CYP2C9 genetic polymorphism.
Cho CK; Kang P; Park HJ; Ko E; Mu CY; Lee YJ; Choi CI; Kim HS; Jang CG; Bae JW; Lee SY
Arch Pharm Res; 2022 May; 45(5):352-366. PubMed ID: 35639246
[TBL] [Abstract][Full Text] [Related]
3. Physiologically based pharmacokinetic (PBPK) modeling to predict the pharmacokinetics of irbesartan in different CYP2C9 genotypes.
Cho CK; Kang P; Jang CG; Lee SY; Lee YJ; Choi CI
Arch Pharm Res; 2023 Dec; 46(11-12):939-953. PubMed ID: 38064121
[TBL] [Abstract][Full Text] [Related]
4. Physiologically based pharmacokinetic (PBPK) modeling of meloxicam in different CYP2C9 genotypes.
Cho CK; Park HJ; Kang P; Moon S; Lee YJ; Bae JW; Jang CG; Lee SY
Arch Pharm Res; 2021 Dec; 44(12):1076-1090. PubMed ID: 34807366
[TBL] [Abstract][Full Text] [Related]
5. Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen.
Loisios-Konstantinidis I; Cristofoletti R; Jamei M; Turner D; Dressman J
Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33147873
[TBL] [Abstract][Full Text] [Related]
6. Physiologically based pharmacokinetic (PBPK) modeling for prediction of celecoxib pharmacokinetics according to CYP2C9 genetic polymorphism.
Kim YH; Kang P; Cho CK; Jung EH; Park HJ; Lee YJ; Bae JW; Jang CG; Lee SY
Arch Pharm Res; 2021 Jul; 44(7):713-724. PubMed ID: 34304363
[TBL] [Abstract][Full Text] [Related]
7. A Physiological-Based Pharmacokinetic Model Embedded with a Target-Mediated Drug Disposition Mechanism Can Characterize Single-Dose Warfarin Pharmacokinetic Profiles in Subjects with Various
Cheng S; Flora DR; Rettie AE; Brundage RC; Tracy TS
Drug Metab Dispos; 2023 Feb; 51(2):257-267. PubMed ID: 36379708
[TBL] [Abstract][Full Text] [Related]
8. Prediction of CYP-mediated silybin A-losartan pharmacokinetic interactions using physiological based pharmacokinetic modeling.
Tanveer A; Hussain K; Tasneem H; Arif I; Rashid M; Abbas N; Shamim R; Shah PA; Bukhari NI
J Pharmacokinet Pharmacodyn; 2022 Jun; 49(3):311-323. PubMed ID: 35061161
[TBL] [Abstract][Full Text] [Related]
9. Drug-drug interaction (DDI) assessments of ruxolitinib, a dual substrate of CYP3A4 and CYP2C9, using a verified physiologically based pharmacokinetic (PBPK) model to support regulatory submissions.
Umehara K; Huth F; Jin Y; Schiller H; Aslanis V; Heimbach T; He H
Drug Metab Pers Ther; 2019 May; 34(2):. PubMed ID: 31145690
[TBL] [Abstract][Full Text] [Related]
10. Effects of CYP2C9*1/*3 genotype on the pharmacokinetics of flurbiprofen in Korean subjects.
Lee YJ; Byeon JY; Kim YH; Kim SH; Choi CI; Bae JW; Sohn UD; Jang CG; Lee J; Lee SY
Arch Pharm Res; 2015 Jun; 38(6):1232-7. PubMed ID: 25712887
[TBL] [Abstract][Full Text] [Related]
11. PBPK modeling to predict the pharmacokinetics of venlafaxine and its active metabolite in different CYP2D6 genotypes and drug-drug interactions with clarithromycin and paroxetine.
Cho CK; Kang P; Jang CG; Lee SY; Lee YJ; Bae JW; Choi CI
Arch Pharm Res; 2024 May; 47(5):481-504. PubMed ID: 38664354
[TBL] [Abstract][Full Text] [Related]
12. Physiologically Based Pharmacokinetic (PBPK) Modeling of Lornoxicam: Exploration of doses for CYP2C9 Genotypes and Patients with Cirrhosis.
Jeong SH; Jang JH; Lee YB
J Pharm Sci; 2022 Nov; 111(11):3174-3184. PubMed ID: 36057318
[TBL] [Abstract][Full Text] [Related]
13. CYP2C9 genotype vs. metabolic phenotype for individual drug dosing--a correlation analysis using flurbiprofen as probe drug.
Vogl S; Lutz RW; Schönfelder G; Lutz WK
PLoS One; 2015; 10(3):e0120403. PubMed ID: 25775139
[TBL] [Abstract][Full Text] [Related]
14. Differences in flurbiprofen pharmacokinetics between CYP2C9*1/*1, *1/*2, and *1/*3 genotypes.
Lee CR; Pieper JA; Frye RF; Hinderliter AL; Blaisdell JA; Goldstein JA
Eur J Clin Pharmacol; 2003 Apr; 58(12):791-4. PubMed ID: 12698304
[TBL] [Abstract][Full Text] [Related]
15. In vitro studies and in silico predictions of fluconazole and CYP2C9 genetic polymorphism impact on siponimod metabolism and pharmacokinetics.
Jin Y; Borell H; Gardin A; Ufer M; Huth F; Camenisch G
Eur J Clin Pharmacol; 2018 Apr; 74(4):455-464. PubMed ID: 29273968
[TBL] [Abstract][Full Text] [Related]
16. Physiologically Based Pharmacokinetic Modelling of Cytochrome P450 2C9-Related Tolbutamide Drug Interactions with Sulfaphenazole and Tasisulam.
Perkins EJ; Posada M; Kellie Turner P; Chappell J; Ng WT; Twelves C
Eur J Drug Metab Pharmacokinet; 2018 Jun; 43(3):355-367. PubMed ID: 29119333
[TBL] [Abstract][Full Text] [Related]
17. Physiologically based pharmacokinetic modeling of candesartan related to CYP2C9 genetic polymorphism in adult and pediatric patients.
Jung EH; Cho CK; Kang P; Park HJ; Lee YJ; Bae JW; Choi CI; Jang CG; Lee SY
Arch Pharm Res; 2021 Dec; 44(12):1109-1119. PubMed ID: 34817825
[TBL] [Abstract][Full Text] [Related]
18. Prediction of the drug-drug interaction potential of the α1-acid glycoprotein bound, CYP3A4/CYP2C9 metabolized oncology drug, erdafitinib.
De Zwart L; Snoeys J; Jacobs F; Li LY; Poggesi I; Verboven P; Goris I; Scheers E; Wynant I; Monshouwer M; Mamidi RNVS
CPT Pharmacometrics Syst Pharmacol; 2021 Sep; 10(9):1107-1118. PubMed ID: 34273250
[TBL] [Abstract][Full Text] [Related]
19. Physiologically based pharmacokinetic (PBPK) modelling of tamsulosin related to CYP2D6*10 allele.
Cho CK; Kang P; Park HJ; Lee YJ; Bae JW; Jang CG; Lee SY
Arch Pharm Res; 2021 Nov; 44(11):1037-1049. PubMed ID: 34751931
[TBL] [Abstract][Full Text] [Related]
20. Differential genotype dependent inhibition of CYP2C9 in humans.
Kumar V; Brundage RC; Oetting WS; Leppik IE; Tracy TS
Drug Metab Dispos; 2008 Jul; 36(7):1242-8. PubMed ID: 18378563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
